Sunday, April 12, 2015

ANTITUMOR ANTIBIOTICS

ANTITUMOR ANTIBIOTICS

·         Interferes with DNA synthesis by binding DNA; prevents RNA synthesis
·         Indication:
o    Target malignancies: Leukemias, Neuroblastoma, Nephroblastoma, breast caner, ovarian cancer, thyroid cancer and lung cancer

·         Contraindication:
o    Lung disease, renal and hepatic disorders, ulcers, and gastrointestinal disease

Example:
bleomycin (Blenoxane®)
dactinomycin (Actinomycin D®, Cosmegan®)
daunorubicin (DaunoXome®, Cerubidine®)
doxorubicin (Adriamycin®)
idarubicin (Idamycin®)
mitomycin (Mutamycin®)
mitoxantrone (Novantorone®)
plicamycin (Mithracin®)
valrubicin (Valstar®)

Side Effects:

·         Bone marrow suppression
·         Nausea and vomiting
·         Alopecia
·         Anorexia
·         Vesication
·         Daunorubicin (DaunoXome), Idarubicin (Idamycin) and Doxorubicin (Adriamycin): cardiotoxicity
·         Bleomycin (Blenoxane): pulmonary toxicity
·         Plicamycin (Mithracin): affects bleeding time

Nursing Considerations:

ü  Assess vital signs and temperature for signs of infection.
ü  Withhold medication if platelet count is <75,000 cells/µL or WBC is <4000 cells/ µL and notify the physician.
ü  Monitor ECG; assess for arrhythmias, gallops and CHF (during dactinomycin [Actinomycin D], daunorubicin [DaunoXome, Cerubidine], Doxorubicin [Adriamycin] therapy.
ü  Monitor CBC with differential, BUN and uric acid.
ü  Assess pulmonary function studies (during Bleomycin [Blenoxane] therapy).
ü  Assess for bleeding; check stool for occult blood. Avoid use of aspirin, anticoagulants and thrombolytic agents (during Plicamycin [Mithracin] therapy).
ü  May see delayed cardiotoxicity months to years after administration of doxorubicin.
ü  To prevent heart failure related to doxorubicin, do not administer more than 550 mg/min a lifetime
ü  Evaluate hydration and nutrition status.
ü  Monitor IV site for vesication.
ü  Instruct oral care for stomatitis.
ü  Teach care for hair loss.

MITOTIC SPINDLE POISONS (Mitotic Inhibitors, Vinca Alkaloids)

·         Arrests metaphase by inhibiting mitotic tubular formation (spindle); inhibit DNA and protein synthesis
·         Indication:
o    Target malignancies: Leukemias, Hodgkin’s and Non-Hodgkin’s lymphomas,lymphocytic and histocytic lymphoma, neuroblastoma, nephroblastoma, Kaposi’s sarcoma, advanced testicular cancer and unresponsive breast cancer 
·         Contraindication: Cardiovascular, hepatic, nerve, and muscle disease


Example:
Plant Alkaloids
o    etoposide (VePesid®)
o    teniposide (Vumon®)
o    vinblastine (Velban®)
o    vincristine (Oncovin®)
o    vinorelbine (Navelbine®)
Taxanes
o    paclitaxel (Nov-Onxol®, Taxol®, Paclitaxel Novaplus®)
o    docetaxel (Txotere®)

Side Effects:

·         Alopecia
·         Hoarseness
·         Ptosis
·         Anorexia, nausea and vomiting
·         Stomatitis
·         Hyperuricemia
·         Constipation, paralytic ileus
·         Vinblastine(Velban®): bone marrow suppression
·         Vincristine (Oncovin®): Neorotoxicity/ neuropathies
·         Taxanes: Bradycardia, hypersensitivity reactions and neuropathies
·         Areflexia

Nursing Considerations:

ü  Assess vital signs.
ü  Monitor CBC with differential.
ü  Assess neuromuscular function.
ü  Evaluate gastrointestinal function; manage constipation.
ü  Administer antiemetics prn as ordered.
ü  Monitor eyes for ptosis; monitor for hoarseness.
ü  Teach ways to manage hair loss.

HORMONAL AGENTS

·         Binds to hormone receptor sites that alter cellular growth; block binding of estrogens to receptor sites (antiestrogens); inhibit RNA synthesis
·         Indication:
o    Target malignancies: Advanced breast and prostate cancer
·         Contraindication:
o    Pregnancy, hepatic and renal disease, osteoporosis, hypertension, hypercholesterolemia

Example:
diethylstilbestrol (DES, Stilphostrol®)
letrozole (Femara®)
raloxifene (Evista®)
tamoxifen (Nolvadex®)
goserilin acetate (Zoladex®)
Testosterone
medroxyprogesterone (Depo- Provera®)
asparaginase (Elspar®)
mitotane (Lysodren®)
megestrol acetate (Megace®)

Side Effects:

·         Hypercalcemia
·         Hypertension
·         Jaundice
·         Increased appetite, weight gain
·         Masculinization
·         Feminization
·         Sodium and fluid retention
·         Hot flashes
·         Vaginal dryness
·         Nausea and vomiting
·         Asparaginase (Eslpar): impaired pancreatic function
·         Mitotane (Lysodren): Hemorrhagic cystitis, hyperuricemia and hypercholesterolemia
·         Tamoxifen (Nolvadex): Edema, hypercalcemia, elevated cholesterol and triglyceride levels, decreased effects of estrogen
·         Diethylstilbestrol (DES, Stilphostrol):
§  Female: Fluid retention, feminization and uterine bleeding
§  Male: impotence and masculinization

Nursing Considerations:

ü  Monitor vital signs.
ü  Administer diuretics prn as ordered.
ü  Monitor for bleeding.
ü  Monitor electrolytes, uric acid and cholesterol levels.
ü  Monitor pancreatic function.
ü  Explain reason for sex characteristic alterations.
ü  Provide patient teachings for managing hot flashes.


No comments:

Post a Comment